Vinati Organics reported a 25% drop in EBITDA for the second quarter of fiscal 2027, with margins falling to 18.5% from 30.4%. Despite the weaker results, Motilal Oswal maintained its buy rating, citing expected growth from capacity expansions and a recovery in specialty chemical demand.
Vinati Organics faced a difficult second quarter for the fiscal year 2027, marked by a sharp decline in profit margins. The company’s EBITDA fell 25% year-on-year to INR 1.2 billion. Most notably, the EBITDA margin compressed significantly to 18.5%, a sharp drop from the 30.4% margin recorded in the same quarter last year. This decline was primarily caused by fluctuations in raw material costs, a challenge the company continues to face.
Following these results, Motilal Oswal released a report maintaining its 'Buy' rating on the stock, though it adjusted its financial expectations. The brokerage has cut its earnings projections for fiscal years 2027 and 2028 by 14% and 7%, respectively. Reflecting these adjustments, the brokerage set a target price of INR 1,270 for the stock.
Despite the immediate margin pressure, the brokerage maintains a positive view on the company’s long-term growth. The optimism is driven by the specialty chemical segment, particularly the ATBS division. The company is currently focusing on the ramp-up of Phase I capacity and ongoing work on Phase II expansion. Additionally, there are early signs of a gradual demand recovery in segments like Butyl Phenol and Isobutyl Benzene, which analysts believe could help improve future revenue streams.
For investors, the primary monitorable will be the company's ability to navigate raw material price volatility. Because specialty chemical manufacturers rely heavily on specific inputs, cost changes can significantly impact profit margins if they cannot be passed on to customers effectively. Investors may also want to track the stabilization of the new Phase II expansion, as any delays in making this capacity productive could affect the company’s return on its capital spending. The management's commentary on demand trends for its key products will remain an important indicator of whether the recovery in the second half of the fiscal year will hold steady.